Tom Brady-backed healthcare startup eMed has raised $200 million in Series A funding, pushing its valuation above $2 billion. The company plans to use the capital to enhance its AI platform and expand employer healthcare programmes, including access to GLP-1 medications. Brady, who serves as founding chief wellness officer, has also invested his own money. The venture adds to his growing business portfolio and wellness industry involvement beyond football.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.